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Abstract: Visual function and retinal morphology were investigated to elucidate the influence 
of ischemia in patients with branch retinal vein occlusion (BRVO) and macular edema. In 41 
consecutive patients with BRVO aged 68.9 ± 10.0 years (22 women and 19 men), the area of 
capillary nonperfusion was measured by fluorescein angiography. Retinal thickness and retinal 
volume were measured by optical coherence tomography, and mean retinal sensitivity was 
calculated for each of 9 macular subfields. Mean visual acuity and macular sensitivity within 
the central subfield were not significantly correlated with the nonperfused area. However, the 
macular sensitivity within the central 5 subfields and all 9 subfields showed significant negative 
correlations with the nonperfused area. Also, macular thickness and volume within all 9 subfields 
were significantly correlated with the nonperfused area. In conclusion, evaluation of both the 
fovea and the entire macular region may be important in patients with ischemic BRVO.
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Introduction
Branch retinal vein occlusion (BRVO) is a common retinal vascular disease that often 
results in macular edema, which is the most frequent cause of visual impairment in 
these patients.1,2 Macular edema can develop at any time during the course of BRVO. 
Increased intravascular pressure and reduced blood flow in macular capillaries can 
lead to dysfunction of the endothelial blood–retinal barrier and to an increase of 
vascular permeability that results in macular edema.3 Vascular endothelial growth 
factor (VEGF) has been suggested to play an important role in the pathogenesis of 
macular edema.4–6 Measurement of visual acuity and measurement of retinal thick-
ness by optical coherence tomography (OCT) are widely considered to be useful for 
determining the treatment strategy in patients with BRVO. However, BRVO causes 
pathological changes (such as bleeding) that not only affect the fovea, but also the 
macular region and the peripheral retina, while visual acuity primarily reflects foveal 
function. Thus, it may be important to obtain a more detailed assessment of the vision 
of these patients.
Recently, microperimetry has been employed to assess visual function in BRVO 
patients with macular edema, and the retinal thickness and retinal sensitivity are reported 
to be related for the entire region of the macula affected by BRVO.7,8 We previously 
demonstrated by microperimetry that retinal thickness and retinal volume are more 
closely associated with retinal sensitivity than with BCVA in BRVO patients who have 
macular edema.9 Parodi et al10 reported that progressive loss of the perifoveal capillary 
network and consequent enlargement of the foveal avascular zone (FAZ) are related to a Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Dovepress
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decrease of visual acuity in BRVO patients. On the other hand, 
Finkelstein11 reported that ischemic edema was associated with 
a good visual prognosis. Thus, ischemia may influence the 
visual acuity of BRVO patients with macular edema.   However, 
the relation of ischemia to macular   sensitivity in BRVO patients 
with macular edema remains unclear.   Accordingly, we investi-
gated both visual function (visual acuity and retinal sensitivity) 
and retinal morphology (retinal thickness and retinal volume) 
in BRVO patients with macular edema to elucidate the influ-
ence of ischemia.
Materials and methods
Patients
This study was performed in accordance with the Helsinki 
Declaration of 1975 (1983 revision), and was approved 
by the ethics committee of Tokyo Women’s Medical 
  University. Forty-one consecutive patients with a mean age 
of 68.9 ± 10.0 years (22 women and 19 men) were included in 
this prospective uncontrolled study conducted in the Depart-
ment of Ophthalmology of Tokyo Women’s Medical Uni-
versity (Table 1). Each patient had unilateral BRVO and the 
mean duration of the condition was 4.5 ± 2.8 months (range: 
1–12 months). Patients were diagnosed as having hyperten-
sion if their systolic blood pressure was $140 mm Hg and 
diastolic blood pressure was .90 mm Hg, or if systolic 
pressure was $140 mm Hg at one examination and dia-
stolic pressure was $90 mm Hg on a different day, or if the 
patient was already taking antihypertensive medication.12 
A diagnosis of hyperlipidemia was based on a total choles-
terol $240 mg/dL, triglycerides $160 mg/dL, low-density 
lipoprotein cholesterol $130 mg/dL, or use of cholesterol-
lowering medication.12
All patients had cystoid macular edema ($250 µm on 
OCT) involving the foveal center. The exclusion criteria were 
1) previous ocular surgery, 2) diabetes mellitus with diabetic 
retinopathy, 3) previous macular laser photocoagulation, 
4) previous intravitreal injection of triamcinolone acetonide 
or anti-VEGF agents, 5) a history of ocular inflammation, 
6) marked retinal hemorrhage (including macular bleeding 
involving the intrafoveal or subfoveal spaces), and 7) serous 
retinal detachment. Twenty-one patients had superior vein 
occlusion and 20 patients had inferior occlusion.
Fundus findings
As baseline screening, patients underwent ophthalmoscopy 
and biomicroscopic examination using a slit-lamp with a 
fundus contact lens. They also underwent standard fundus 
color photography and fluorescein angiography, which was 
performed with a Topcon TRC-50EX fundus camera, an 
image-net system (Tokyo Optical Co. Ltd., Japan), and a 
preset lens with a slit-lamp.
A masked grader independently assessed ischemic retinal 
vascular occlusion on the fluorescein angiograms by measur-
ing the ischemic area of the retina with the public domain 
Scion Image program, as reported previously.4–6 On digital 
photographs of the fundus, the optic disc was outlined with a 
cursor, then its area was measured, as was also done for the 
nonperfused area of the retina. Then the nonperfused area 
was divided by the disc area to calculate the severity of retinal 
ischemia. The average nonperfused area was 34.7 ± 34.8 disc 
areas, with a range of 0 to 117 disc areas.
In addition, retinal sensitivity was investigated by micro-
perimetry, and retinal thickness and retinal volume were 
measured by OCT.
Measurement of BCVA
Each patient underwent measurement of best-corrected 
visual acuity (BCVA) with an SC-2000 System chart (Nidek, 
Gamagori, Japan). BCVA was measured in decimal units on 
a Landolt chart by the orthopticists. The chart brightness was 
set at 80 to 320 cd/m2, and chart contrast was more than 74%. 
The results were converted to the logarithm of the minimum 
angle of resolution scale (logMAR).
Optical coherence tomography
OCT was performed with an instrument from   Zeiss-Humphrey 
Ophthalmic Systems (Zeiss Stratus OCT3, Carl Zeiss   Meditec, 
Dublin, CA) to measure the foveal thickness. At each visit, all 
patients underwent Stratus OCT examination in the vertical 
cross-section with the instrument centered on the fovea and 
in the fast macular thickness mode. On these views, retinal 
thickness was defined as the distance between the inner 
surface of the neurosensory retina and the retinal pigment 
epithelium. Foveal thickness was calculated as the average 
retinal thickness within a circle of 500 µm radius centered 
Table 1 Clinical and demographic data of the BRVO patients
No (M/F) 41 (19/22)
Age (yrs) 68.9 ± 10.0∗
hypertension 30 (73.2%)
  systolic blood pressure (mmhg) 137 ± 16∗
  Diastolic blood pressure (mmhg) 82 ± 11∗
hyperlipidemia 18 (43.9%)
Duration of BRVO (months) 4.5 ± 2.8∗
BCVA (logMAR) 20/60 (0.55 ± 0.38∗)
Note: Data are shown as the number (%) or the mean ± standard deviation.
Abbreviations: BRVO, branch retinal vein occlusion; No, number of eyes; M, male; 
F, female; logMAR, logarithm of the minimum angle of resolution scale.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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on the fovea. A retinal thickness map and retinal volume 
map were obtained by scanning 6 × 6 mm (20° × 20°) areas 
of the macular region, which was divided into 9 subfields: 
1) fovea, 2) superior inner macula, 3) nasal inner macula, 
4) inferior inner macula, 5) temporal inner macula, 6) superior 
outer macula, 7) nasal outer macula, 8) inferior outer macula, 
and 9) temporal outer macula.9 The diameters of the central, 
inner, and outer circles were 1, 3, and 6 mm, respectively. 
In each region, measurement of retinal thickness and volume 
was automatically performed by computer software. The 
mean macular thickness at the one subfield (fovea) covering 
the central 1 × 1 mm (4° × 4°), at 5 subfields (fovea, superior 
inner, nasal inner, inferior inner, and temporal inner) cover-
ing the central 3 × 3 mm (10° × 10°), and at all 9 subfields 
covering the entire central 6 × 6 mm (20° × 20°) were thus 
determined.
Retinal volume was calculated as follows. A central 
macular thickness map measuring 6.00 mm in diameter was 
generated. The circular map was subdivided into 9 quadrants. 
The middle and inner circle diameters were 3.00 mm and 
1.00 mm, respectively. The mean retinal thickness was cal-
culated for each of the 9 quadrants from the obtained radial 
scans. Multiplying the mean retinal thickness by the area of 
the quadrant generated the volume for each of the 9 quadrants. 
The total macular volume at the 1 subfield (fovea) covering 
the central 1 × 1 mm (4° × 4°), at 5 subfields (fovea, superior 
inner, nasal inner, inferior inner, and temporal inner) cover-
ing the central 3 × 3 mm (10° × 10°), and at all 9 subfields 
covering the entire central 6 × 6 mm (20° × 20°) were thus 
determined as the sum of the quadrant volume.
Functional mapping by microperimetry
Microperimetry was performed with the MP-1 micrope-
rimeter (Nidek, Gamagori, Japan) using an infrared fundus 
camera with a liquid crystal display controlled by dedicated 
software. The MP-1 performs microperimetry and assesses 
fixation independently with an automated eye tracking system 
that provides real-time compensation for eye movements 
and therefore allows presentation of a stimulus at precisely 
the predefined retinal location. That is, if the reference area 
moves, the stimulus is also automatically moved, while the 
stimulus is not delivered if the reference area cannot be 
detected. The retinal sensitivity threshold can be measured 
easily because the strength of the stimulus is altered automati-
cally and progressively during microperimetry. Color fundus 
photographs can also be acquired and the findings can be 
registered either automatically or manually along with the 
infrared image. At the end of testing, microperimetry data 
can also be superimposed on the digital fundus photograph. 
Thus, microperimetry is performed while observing a target 
set on the fundus, so the target is precisely located and testing 
is reliable even in patients who do not have stable fixation.
Each patient underwent fundus-monitored microperim-
etry with the MP-1 system (Nidek, Gamagori, Japan). Its 
software performs automatic tracking of fundus movements 
and evaluates every frame acquired for fundus shift in the 
x and y directions relative to a reference frame obtained 
with an infrared camera at the start of the examination. 
  Microperimetry settings were identical for all examina-
tions, and   Goldmann III stimuli were presented in random 
order according to a 4-2-1 double staircase strategy. The 
stimulus intensity ranged from 0 to 20 decibels (dB) 
(0 dB corresponded to the strongest signal intensity of 
127 cd/m2) in 1-dB steps, and the duration of each stimulus 
was 200 milliseconds. The target was varied in size according 
to the patient’s visual acuity. Retinal sensitivity maps were 
obtained by using the macula 20° program of the MP-1. 
Mean retinal sensitivity was calculated from the sensitivity 
in each of the 9 subfields on the retinal map generated by 
OCT.9 The mean macular sensitivity was determined for 5 
locations covering the central 4° field, 29 locations covering 
the central 10° field (5 subfields: fovea, superior inner, nasal 
inner, inferior inner, and temporal inner), and 57 locations 
covering the entire central 20° field (all 9 subfields).
statistical analysis
All analyses were performed with SAS System 9.1 software 
(SAS Institute Inc., Cary, NC). Results are presented as 
the mean ± SD or frequency. To examine the relationship 
between visual acuity (logMAR) or retinal sensitivity and 
the severity of retinal ischemia, as well as the relationship 
between retinal thickness or retinal volume and the severity 
of retinal ischemia, Pearson’s correlation coefficients were 
calculated. Two-tailed P values of less than 0.05 were con-
sidered to indicate statistical significance.
Results
BCVA ranged from 20/200 to 20/25 (median: 20/60), with 
the mean logMAR value being 0.55 ± 0.38 (range: 0 to 1.2) 
(Table 1). Table 2 shows the mean macular sensitivity, 
macular thickness, and macular volume within the central 
4°, 10°, and 20° fields.
Visual acuity (logMAR) was not significantly correlated 
with the nonperfused area (ρ = 0.16, P = 0.317) (Figure 1). 
Macular sensitivity within the 10° and 20° fields showed 
significant negative correlations with the nonperfused area Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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(ρ = -0.35, P = 0.021, and ρ = -0.36, P = 0.020, respectively), 
but the macular sensitivity within the central 4° field was not 
significantly correlated with the nonperfused area (ρ = -0.25, 
P = 0.108) (Figures 2A–2C). Although macular thickness 
within the 20° field was significantly correlated with the 
nonperfused area (ρ = 0.33, P = 0.037), the macular thick-
ness within the central 4° or 10° fields was not significantly 
correlated with the nonperfused area (ρ = 0.28, P = 0.071, and 
ρ = 0.27, P = 0.092, respectively) (Figures 3A–3C). Likewise, 
macular volume within the 20° field was significantly cor-
related with the nonperfused area (ρ = 0.36, P = 0.019), but 
macular volume within the central 4° or 10° fields was not 
(ρ = 0.29, P = 0.062, and ρ = 0.26, P = 0.103, respectively) 
(Figures 4A–4C).
Discussion
With regard to the sensitivity of the techniques that we 
employed, we previously reported that macular sensitivity 
Table 2 Functional and anatomic measurements in the BRVO 
patients with macular edema
Subfield Macular  
sensitivity (dB)
Macular  
thickness (μm)
Macular  
volume (mm3)
4° field 6.55 ± 5.64∗ 470 ± 144∗ 0.37 ± 0.11∗
10° field 7.87 ± 4.63∗ 425 ± 94∗ 2.97 ± 0.64∗
20° field 8.39 ± 4.22∗ 382 ± 71∗ 9.93 ± 1.66∗
Note: ∗Mean ± standard deviation.
Abbrreviation: BRVO, branch retinal vein occlusion.
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Figure  1  Correlation  between  best-corrected  visual  acuity  (BCVA)  converted 
to  the  logarithm  of  the  minimum  angle  of  resolution  scale  (logMAR)  and  the 
nonperfused area. The visual acuity (logMAR) was not significantly correlated with 
the nonperfused area in BRVO patients with macular edema (ρ = 0.16, P = 0.317).
Figure 2 Correlation between macular sensitivity and the nonperfused area in 
BRVO patients with macular edema. A) Macular sensitivity within the central 4° was 
not significantly correlated with the nonperfused area (ρ = -0.25, P = 0.108), but 
macular sensitivity within the (B) 10° field and (C) the 20° field showed significant 
negative correlations with the nonperfused area (ρ = -0.35, P = 0.021, and ρ = -0.36, 
P = 0.020, respectively).
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Figure  3  Correlation  between  macular  thickness  and  the  nonperfused  area  in 
BRVO patients with macular edema. The macular thickness within the central (A) 4° 
field or (B) the 10° field was not significantly correlated with the nonperfused area 
(ρ = 0.28, P = 0.071, and ρ = 0.27, P = 0.092, respectively), but the macular thickness 
within the 20° field (C) showed a significant correlation with the nonperfused area 
(ρ = 0.33, P = 0.037).
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Figure 4 Correlation between macular volume and the nonperfused area in BRVO 
patients with macular edema. The macular volume within the central (A) 4° field 
or (B) the 10° field was not significantly correlated with the nonperfused area 
(ρ = 0.29, P = 0.062, and ρ = 0.26, P = 0.103, respectively). however, the macular 
volume within the 20° field (C) was significantly correlated with the nonperfused 
area (ρ = 0.36, P = 0.019).
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was correlated with both macular thickness and volume in all 
9 subfields of patients with BRVO and macular edema.9 Such 
findings suggest that our techniques are sensitive for detect-
ing central local deficits in patients with BRVO and macular 
edema. However, the present study demonstrated that the 
mean visual acuity (logMAR) and macular sensitivity within 
the central 4° field were not significantly correlated with the 
nonperfused area in BRVO patients with macular edema. 
It has been reported that progressive loss of the perifoveal 
capillary network with enlargement of the FAZ is related to 
a decrease of visual acuity in BRVO patients.10 Therefore, 
foveal function (including visual acuity) may depend more on 
the extent of damage to the perifoveal capillary network than 
on the nonperfused area after BRVO, although why foveal 
function reflects the perifoveal capillary network rather than 
the nonperfused area is still unclear. Tyrberg et al13 reported a 
significant correlation between an increase of FAZ diameter 
and an increase in the implicit time of the innermost concen-
tric rings and of the third concentric ring in the first order 
kernel on multifocal electroretinography (mfERG), while 
an increase of the total area (FAZ and perifoveal intercapil-
lary areas) was correlated with an increase in the implicit 
time in the same areas on the mfERG. This suggests that a 
larger nonperfused area is associated with greater alteration 
of neuronal function in the macular region due to ischemia. 
Therefore, it is possible that the mean visual acuity (logMAR) 
and macular sensitivity within the central 4° field were not 
significantly correlated with the nonperfused area in BRVO 
patients with macular edema because alterations of neuronal 
function due to ischemia were minor due to the small size of 
the nonperfused area. Furthermore, Tyrberg et al13 concluded 
that alterations of neuronal function in the macular region due 
to ischemia might precede the deterioration of visual acuity 
because the ischemic area was correlated with prolongation 
of the implicit time regardless of whether visual acuity was 
preserved (0.6 or better). Thus, deterioration of visual acu-
ity might occur after alterations of neuronal function due to 
ischemia. On the other hand, macular sensitivity within the 
10° and 20° fields showed significant negative correlations 
with the nonperfused area. Because photoreceptor cells are 
damaged by retinal ischemia, functional retinal impairment 
may become more severe as the ischemic region increases. 
Thus, evaluation of visual function not only for the fovea but 
also the entire macular region may be important in patients 
with ischemic BRVO.
We also found that the macular thickness and volume 
within the 20° field were significantly correlated with the 
nonperfused area. Interestingly, macular sensitivity and 
macular thickness/volume within the 20° field showed 
parallel changes in the present study. We recently reported 
that increased intraocular levels of VEGF and sICAM-1 or 
a decreased level of PEDF are associated with increased 
vascular permeability and the severity of retinal ischemia 
in BRVO patients.14,15 Thus, when the severity of ischemia 
increases, changes in these factors result in an increase of 
macular edema. As macular edema increases, ischemia 
also worsens, with the result that macular function may be 
impaired. This hypothesis is supported by previous reports 
that the retinal thickness at the central fovea influences visual 
function in BRVO patients.16–19 In addition, tissue expan-
sion due to edema could stretch the capillary network and 
lead to transient capillary closure because of the high tissue 
fluid pressure in patients with ischemic macular edema.11 
Progressive capillary occlusion may contribute to ischemic 
macular edema, resulting in the functional impairment of 
photoreceptor cells. Taken together, these findings suggest 
that functional and mechanical damage to photoreceptor 
cells due to ischemic macular edema might reduce macular 
sensitivity.
One limitation of the present study is that the macular 
thickness/volume, macular sensitivity, and visual acuity 
may change due to the natural course of the disease after the 
onset of BRVO. Because this was a cross-sectional study, a 
longitudinal investigation would be needed to clarify the rela-
tions between macular thickness/volume, macular sensitivity, 
and visual acuity in BRVO patients. Second, Finkelstein11 
reported that ischemic edema was associated with a good 
visual prognosis. Because our study was cross-sectional, it 
did not provide data on the response to treatment or the prog-
nosis of the patients, such as whether those with or without 
ischemia had any particular outcomes. Third, because it has 
been reported that diffuse disorganization of the outer pho-
toreceptor layer beneath the fovea often results in poor visual 
acuity even after complete resolution of macular edema,20 it 
is also possible that such diffuse disorganization of the outer 
photoreceptor layer could have influenced visual function in 
our subjects. However, we could not assess the relationship of 
the outer photoreceptor layer to the visual prognosis because 
detection of the junction between the inner and outer layers 
was difficult with our OCT equipment. Accordingly, the 
prognosis of patients with BRVO and macular edema needs 
to be investigated in more detail in the future.
In conclusion, we found that mean visual acuity 
(logMAR) and the macular sensitivity within the central 4° 
field were not significantly correlated with the nonperfused 
area in BRVO patients with macular edema, while the Clinical Ophthalmology
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macular sensitivity within the 10° and 20° fields showed 
significant negative correlations with the nonperfused area. 
The macular thickness and volume within the 20° field was 
also significantly correlated with the nonperfused area. These 
findings suggest that evaluation not only of the fovea but also 
the entire macular region may be important in patients with 
ischemic BRVO and macular edema.
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